1 documents found
Information × Registration Number 0115U000675, R & D request Title 26-week, randomized, double-blind, active-controlled, multicenter, international, parallel-group study of safety and risk assessment of serious asthma-related phenomena in the treatment Symbikortom® - fixed combination of inhaled corticosteroids (ICS) (budesonide) and ?2- agonist long-term action (LABA) (formoterol) compared with treatment only ICS (budesonide) in adults and adolescents (? 12 years) with asthma Head Бойко Микола Григорович, Registration Date 02-03-2015 Organization Ukrainian medical stomatological Academy popup.description1 popup.nrat_date 2024-12-10 Close
search.res_rk
26-week, randomized, double-blind, active-controlled, multicenter, international, parallel-group study of safety and risk assessment of serious asthma-related phenomena in the treatment Symbikortom® - fixed combination of inhaled corticosteroids (ICS) (budesonide) and ?2- agonist long-term action (LABA) (formoterol) compared with treatment only ICS (budesonide) in adults and adolescents (? 12 years) with asthma
Head: Бойко Микола Григорович. 26-week, randomized, double-blind, active-controlled, multicenter, international, parallel-group study of safety and risk assessment of serious asthma-related phenomena in the treatment Symbikortom® - fixed combination of inhaled corticosteroids (ICS) (budesonide) and ?2- agonist long-term action (LABA) (formoterol) compared with treatment only ICS (budesonide) in adults and adolescents (? 12 years) with asthma. Ukrainian medical stomatological Academy. № 0115U000675
1 documents found

Updated: 2026-03-19


Роздрукувати цю сторінку